Detalles de la búsqueda
1.
US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
Genet Med
; 24(1): 238-244, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906461
2.
Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.
J Genet Couns
; 31(1): 130-139, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34231930
3.
Genetic counselors' experience with reimbursement and patient out-of-pocket cost for multi-cancer gene panel testing for hereditary cancer syndromes.
J Genet Couns
; 31(6): 1394-1403, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900261
4.
Assessing Breast Cancer Risks to Improve Care for an Increased-Risk Population within Eastern North Carolina.
N C Med J
; 83(3): 221-228, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35504701
5.
Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
Genet Med
; 22(2): 283-291, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31501586
6.
Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond.
J Natl Compr Canc Netw
; : 1-7, 2020 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998106
7.
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Value Health
; 23(5): 551-558, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32389219
8.
Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
Genet Med
; 21(1): 152-160, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29997388
9.
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Value Health
; 21(9): 1062-1068, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224110
10.
Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.
Genet Med
; 19(5): 559-567, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27657682
11.
Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
J Natl Compr Canc Netw
; 15(2): 219-228, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188191
12.
"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.
Value Health
; 20(1): 47-53, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212968
13.
Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
Value Health
; 20(1): 40-46, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212967
14.
Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
J Natl Compr Canc Netw
; 13(3): 311-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25736008
15.
Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs.
JAMA
; 321(24): 2403-2404, 2019 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31145414
16.
Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.
Health Aff Sch
; 1(1): qxad005, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756840
17.
Resource and Reimbursement Barriers to Comprehensive Cancer Care Delivery: An Analysis of Association of Community Cancer Centers Survey Data.
JCO Oncol Pract
; 19(3): e428-e438, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521094
18.
Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions.
JCO Oncol Pract
; 19(1): e125-e137, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178937
19.
Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.
J Community Genet
; 13(1): 75-80, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34743282
20.
Evaluation of the Novel 4R Oncology Care Planning Model in Breast Cancer: Impact on Patient Self-Management and Care Delivery in Safety-Net and Non-Safety-Net Centers.
JCO Oncol Pract
; 17(8): e1202-e1214, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34375560